Mayo Clinic Laboratory and Pathology Research Roundup: January 9

By Sarah Jarvis • January 9, 2024

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Anakinra-associated systemic amyloidosis.

To describe a 41-year-old woman with a history of neonatal onset multisystem inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor antagonist (IL-1Ra) protein, anakinra, since the age of 28, who presented with golf-ball size nodules at the anakinra injection sites, early satiety, new onset nephrotic syndrome in the context of normal markers of systemic inflammation.

Read more.

Published to PubMed This Week

• Breast cancer polygenic risk score influence on risk-reducing endocrine therapy use: Genetic risk estimate (GENRE) trial 1-year and 2-year follow-up.
  Cancer Prevention Research
• The evolving role of artificial intelligence in gastrointestinal histopathology: An update.
  Clinical Gastroenterology and Hepatology
• Genomic and evolutionary characterization of concurrent intraductal carcinoma and adenocarcinoma of the prostate.
  Cancer Research
• Seventy-five years of service: an overview of the College of American Pathologists' proficiency testing program in histocompatibility and identity testing.
  Frontiers in Genetics
• At-home molecular diagnostics: Just around the corner or years away?
  The Journal of Applied Laboratory Medicine

Sarah Jarvis

Sarah Jarvis is a Senior Marketing Specialist at Mayo Clinic Laboratories. She supports marketing strategies for paid media.